Grants We Funded
Grant applicants for the 2022 cycle requested a total of over $2.9 million dollars. The PSF Study Section subcommittees of Basic & Translational Research and Clinical Research evaluated 115 grant applications on the following topics:
The PSF awarded research grants totaling almost $550,000 to support 19 plastic surgery research proposals.
ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.
Research Abstracts
Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.
Single Cell Analysis of SDF-1 Mediated Stem Cell Recruitment
Zeshaan Maan MD · Stanford University
Single cell transcriptional analysis of fibroblasts in Dupuytren disease
Janos Barrera MD · Stanford University
Single-agent Immunomodulation in Pediatric Craniofacial CTA
Joseph Losee MD · University of Pittsburgh
Sirtuin Regulation of Aging Human Adipose Tissue
Ivona Percec MD PhD · The Trustees of the University of Pennsylvania
Skeletal muscle regeneration by human satellite cells following denervation
Alvin Wong MD · The Regents of the University of California, San Francisco
Skin Improvement in Radiatiation Wounds: The Impact of Adipose Derived Stem Cells
Tim Daugherty MD · Southern Illinois University School of Medicine
Skin Regenerative Potential of ADSCs: in vivo Nude Mouse Model
Brian Derby MD · Southern Illinois University
Skin Tape Stripping to Assess Cytokine Expression Profiles
Gerald Brandacher MD · Johns Hopkins University
Smart Scaffolds for Soft-Tissue Engineering
Julio Clavijo-Alvarez MD · University of Pittsburgh
Spitzoid Nevi Versus Melanoma by Cellular Gp100, Nedd9 and Gab2
Matthew McRae MD, FRCSC · Yale School of Medicine